Intelligent Bio Solutions Inc.
INBS
$2.47
$0.041.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 35.77% | 45.53% | 47.62% | 27.46% | 15.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.77% | 45.53% | 47.62% | 27.46% | 15.95% |
| Cost of Revenue | 19.85% | 35.59% | 13.68% | 12.94% | 679.59% |
| Gross Profit | 59.89% | 56.82% | 106.05% | 49.45% | -58.85% |
| SG&A Expenses | 9.80% | 1.82% | 29.18% | 36.47% | 1.96% |
| Depreciation & Amortization | -4.03% | -3.84% | -7.63% | 1.00% | 5.55% |
| Other Operating Expenses | 35.89% | 4.39% | 45.58% | -53.29% | -392.81% |
| Total Operating Expenses | 36.99% | 21.69% | 22.05% | 7.01% | 5.39% |
| Operating Income | -37.35% | -14.90% | -15.20% | -0.46% | -2.65% |
| Income Before Tax | -26.26% | -12.50% | -19.04% | -11.14% | -10.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.26% | -12.50% | -19.04% | -11.14% | -10.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -21.60% | -2.82% | 23.29% | 30.43% | 12.61% |
| Net Income | -26.46% | -12.55% | -19.03% | -11.07% | -10.99% |
| EBIT | -37.35% | -14.90% | -15.20% | -0.46% | -2.65% |
| EBITDA | -33.54% | -14.83% | -20.35% | 0.15% | -2.02% |
| EPS Basic | 64.61% | 59.26% | 43.22% | 50.47% | 51.78% |
| Normalized Basic EPS | 61.90% | 59.32% | 43.80% | 54.84% | 55.23% |
| EPS Diluted | 64.61% | 59.26% | 43.22% | 50.47% | 51.87% |
| Normalized Diluted EPS | 61.90% | 59.32% | 43.80% | 54.84% | 55.23% |
| Average Basic Shares Outstanding | 257.35% | 176.25% | 109.61% | 124.27% | 130.15% |
| Average Diluted Shares Outstanding | 257.35% | 176.25% | 109.61% | 124.27% | 130.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |